EUVIMEDEUVIMED entdecken
Crossref

FTO/ZNF334 suppresses prostate cancer enzalutamide resistance through androgen receptor ubiquitination

Changde Fu, Jun Xin, Wei Zhang, Jinjin Lai, Liefu Ye

Molecular and Cellular Endocrinology · 2026-11 · 112951

DOI: 10.1016/j.mce.2026.112951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-11. Verfasst von Changde Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou City, Fujian Province, 350001, P.R., China; Department o…. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Enzalutamide (ENZ) resistance remains a major therapeutic challenge in prostate cancer (PCa), with mechanisms incompletely elucidated. The role and regulation of ZNF334 in this resistance are undefined. METHODS: ZNF334 expression was analyzed bioinformatically in ENZ-resistant PCa datasets and validated in vitro and clinical levels. The ENZ-resistant PCa cell line C4-2B-ENZR was established, with ZNF334 expression determined by qRT-PCR and Western blot. ZNF334's effects on ENZ sensitivity, proliferation, apoptosis, and invasion of C4-2B-ENZR cells were assessed via CCK-8, colony formation, flow cytometry, and Transwell assays. ZNF334-TRIM28 interaction was predicted bioinformatically and confirmed by Co-IP and immunofluorescence. The ubiquitination and expression of AR and AR-V7 were evaluated by Western blot and immunoprecipitation. The FTO-ZNF334 regulatory axis was examined by MeRIP, RNA pull-down, and actinomycin D assays, and further validated using an FTO mutant construct. Tumor growth and pathological injuries were monitored in a mouse xenograft model, with molecular expression and apoptosis analyzed by IHC and TUNEL staining. RESULTS: ZNF334 was downregulated in ENZ-resistant PCa; overexpressing ZNF334 increased ENZ sensitivity, suppressed proliferation and invasion, and induced apoptosis in C4-2B-ENZR cells. Mechanistically, FTO stabilized ZNF334 mRNA by erasing its m6A modification, promoting ZNF334-TRIM28 interaction, and accelerating AR ubiquitination and degradation. In vivo, FTO-mediated ZNF334 upregulation inhibited tumor growth and ENZ resistance. CONCLUSION: FTO enhances ZNF334 mRNA stability via m6A demethylation, facilitating ZNF334/TRIM28-mediated AR ubiquitination and degradation to suppress ENZ resistance in PCa. This identifies a novel potential therapeutic target for overcoming PCa drug resistance.

Schlagwörter

Stichwörter der Autor:innen

AR ubiquitinationFTOZNF334enzalutamide resistanceprostate cancer

Autor:innen und Institutionen

  • Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou City, Fujian Province, 350001, P.R., China; Department of Urology, Quanzhou First Hospital affiliated to Fujian Medical Univer…
  • Department of Urology, Quanzhou First Hospital affiliated to Fujian Medical University, Quanzhou City, Fujian Province, 362000, P.R., China.
  • Department of Urology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou City, Fujian Province, 350001, P.R., China. Electronic address: yeliefu@fjmu.edu.cn.

Zitieren

APA

Fu, C., Xin, J., Zhang, W., Lai, J., & Ye, L. (2026). FTO/ZNF334 suppresses prostate cancer enzalutamide resistance through androgen receptor ubiquitination. Molecular and Cellular Endocrinology, 112951. https://doi.org/10.1016/j.mce.2026.112951

Vancouver

Fu C, Xin J, Zhang W, Lai J, Ye L. FTO/ZNF334 suppresses prostate cancer enzalutamide resistance through androgen receptor ubiquitination. Molecular and Cellular Endocrinology. 2026:112951. doi:10.1016/j.mce.2026.112951

BibTeX
@article{Fu2026,
  author = {Fu, Changde and Xin, Jun and Zhang, Wei and Lai, Jinjin and Ye, Liefu},
  title = {FTO/ZNF334 suppresses prostate cancer enzalutamide resistance through androgen receptor ubiquitination},
  journal = {Molecular and Cellular Endocrinology},
  year = {2026},
  pages = {112951},
  doi = {10.1016/j.mce.2026.112951}
}
Kostenlos starten →